# Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition

> **NCT01504516** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Donepezil Hydrochloride
- **DRUG:** Aricept

## Key facts

- **NCT ID:** NCT01504516
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2012-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01504516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01504516, "Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01504516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*